Imaging for early stage breast cancer

Evolution of techniques

• Cobalt-60 and 2D dosimetry

➢ Clinical target volume defined by clinical examination

➢ Effective dose is deliverd to breast ➢ Not always homogeneous ➢ Potentially toxic doses at OAR

➢ skin ➢ lung ➢ heart